ATG3 and lung adenocarcinoma: These results lead us to deduce that Atg3 may be a key regulator/promoter of ER in EGFR overexpressed lung adenocarcinoma and targeting baseline over expression/translation of Atg3 may be able to result in the reversal of ER.